Clinical Trial Results:
Multicenter, randomised, double-blind Phase III trial to investigate the efficacy and safety of BIBF 1120 in combination with carboplatin and paclitaxel compared to placebo plus carboplatin and paclitaxel in patients with advanced ovarian cancer
Summary
|
|
EudraCT number |
2008-006831-10 |
Trial protocol |
DE FR SE BE PT SK DK AT NL FI PL IT GR CZ ES GB |
Global completion date |
29 Apr 2013
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1 |
This version publication date |
16 May 2016
|
First version publication date |
22 Mar 2015
|
Other versions |
v2 , v3 |
Summary report(s) |
1199.15 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.